23 May 2013
Keywords: first, launch, ucb, kentera, oab, belgian, drugmaker
Article | 25 April 2005
Belgian drugmaker UCB has kicked off a phased European introduction of Kentera, its novel oxybutynin transdermal patch for overactive bladder,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 April 2005
© 2013 thepharmaletter.com